914
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET

, , , , &
Pages 619-626 | Received 09 Mar 2012, Accepted 02 Jun 2012, Published online: 08 Aug 2012

References

  • Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 2012;99:918–28.
  • Kusters M, Valentini V, Calvo FA, Krempien R, Nieuwenhuijzen GA, Martijn H, . Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: Adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol 2010;21:1279–84.
  • Maas M, Nelemans PJ, Valentini V, Das P, Rodel C, Kuo LJ, . Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol 2010;11:835–44.
  • Zhang C, Tong J, Sun X, Liu J, Wang Y, Huang G. (18) F-FDG-PET evaluation of treatment response to neo- adjuvant therapy in patients with locally advanced rectal cancer: A meta-analysis. Int J Cancer Epub2012 Mar 24.
  • Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, . Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007;34:1583–93.
  • Vliegen RF, Beets-Tan RG, Vanhauten B, Driessen A, Oellers M, Kessels AG, . Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?Strahlenther Onkol 2008;184:457–64.
  • Amthauer H, Denecke T, Rau B, Hildebrandt B, Hunerbein M, Ruf J, . Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 2004;31:811–9.
  • Cascini GL, Avallone A, Delrio P, Guida C, Tatangelo F, Marone P, . 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006;47: 1241–8.
  • Janssen MH, Ollers MC, Riedl RG, van den Bogaard J, Buijsen J, van Stiphout RG, . Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys 2010;77:392–9.
  • Haustermans K, Debucquoy A, Lambrecht M. The ESTRO Breur Lecture 2010: Toward a tailored patient approach in rectal cancer. Radiother Oncol 2011;100:15–21.
  • Hatt M, Visvikis D, Pradier O, Cheze-le Rest C. Baseline (18)F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer. Eur J Nucl Med Mol Imaging 2011;38:1595–606.
  • Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, . Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999; 2:159–71.
  • Tixier F, Le Rest CC, Hatt M, Albarghach N, Pradier O, Metges JP, . Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 2011;52:369–78.
  • Cazaentre T, Morschhauser F, Vermandel M, Betrouni N, Prangere T, Steinling M, . Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 2010;37:494–504.
  • Lee HY, Hyun SH, Lee KS, Kim BT, Kim J, Shim YM, . Volume-based parameter of (18)F-FDG PET/CT in malignant pleural mesothelioma: Prediction of therapeutic response and prognostic implications. Ann Surg Oncol 2010;17:2787–94.
  • El Naqa I, Grigsby P, Apte A, Kidd E, Donnelly E, Khullar D, . Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 2009;42:1162–71.
  • Melton GB, Lavely WC, Jacene HA, Schulick RD, Choti MA, Wahl RL, . Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg 2007;11:961–9; discussion 969.
  • Chennupati SK, Quon A, Kamaya A, Pai RK, La T, Krakow TE, . Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Am J Clin Oncol Epub2011 Mar 17.
  • Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, . Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680–6.
  • Boussion N, Cheze Le Rest C, Hatt M, Visvikis D. Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging. Eur J Nucl Med Mol Imaging 2009;36:1064–75.
  • Lucy LB. An iterative technique for the rectification of observed distributions. Astronom J 1974;79:745.
  • Richardson WH. Bayesian-based iterative method of image restoration. J Optical Soc Am 1972;62:55.
  • Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, . Partial-volume correction in PET: Validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med 2007;48:802–10.
  • Chang SG, Yu B, Vetterli M. Adaptive wavelet thresholding for image denoising and compression. IEEE Trans Image Process 2000;9:1532–46.
  • Hatt M, Cheze le Rest C, Descourt P, Dekker A, De Ruysscher D, Oellers M, . Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications. Int J Radiat Oncol Biol Phys 2010;77:301–8.
  • Hatt M, Cheze Le Rest C, Albarghach N, Pradier O, Visvikis D. PET functional volume delineation: A robustness and repeatability study. Eur J Nucl Med Mol Imaging 2011; 38:663–72.
  • Hatt M, Cheze-Le Rest C, Aboagye EO, Kenny LM, Rosso L, Turkheimer FE, . Reproducibility of 18F-FDG and 3’-deoxy-3’-18F-fluorothymidine PET tumor volume measurements. J Nucl Med 2010;51:1368–76.
  • Hatt M, Le Pogam A, Visvikis D, Pradier O, Cheze le Rest C. Impact of partial volume effects correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer. J Nucl Med 2012;53:12–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.